SG131946A1 - Ccr3 receptor antagonists - Google Patents
Ccr3 receptor antagonistsInfo
- Publication number
- SG131946A1 SG131946A1 SG200702988-7A SG2007029887A SG131946A1 SG 131946 A1 SG131946 A1 SG 131946A1 SG 2007029887 A SG2007029887 A SG 2007029887A SG 131946 A1 SG131946 A1 SG 131946A1
- Authority
- SG
- Singapore
- Prior art keywords
- receptor antagonists
- ccr3 receptor
- ccr3
- antagonists
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
- C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51429603P | 2003-10-24 | 2003-10-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG131946A1 true SG131946A1 (en) | 2007-05-28 |
Family
ID=34520190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200702988-7A SG131946A1 (en) | 2003-10-24 | 2004-10-14 | Ccr3 receptor antagonists |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20050090504A1 (es) |
| EP (1) | EP1680408A2 (es) |
| JP (1) | JP2007509095A (es) |
| KR (1) | KR20060061393A (es) |
| CN (1) | CN1871222A (es) |
| AR (1) | AR046340A1 (es) |
| AU (1) | AU2004283842A1 (es) |
| BR (1) | BRPI0415767A (es) |
| CA (1) | CA2543419A1 (es) |
| MX (1) | MXPA06004304A (es) |
| RU (1) | RU2006117631A (es) |
| SG (1) | SG131946A1 (es) |
| TW (1) | TW200522957A (es) |
| WO (1) | WO2005040129A2 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101563319B (zh) | 2006-12-19 | 2012-09-05 | 弗·哈夫曼-拉罗切有限公司 | 杂芳基吡咯烷基和哌啶基甲酮衍生物 |
| KR20110010783A (ko) * | 2008-06-18 | 2011-02-07 | 에프. 호프만-라 로슈 아게 | Ｍｒｉ로서의 아릴 케톤 |
| US8278302B2 (en) | 2009-04-08 | 2012-10-02 | Boehringer Ingelheim International Gmbh | Substituted piperidines as CCR3 antagonists |
| WO2010129351A1 (en) | 2009-04-28 | 2010-11-11 | Schepens Eye Research Institute | Method to identify and treat age-related macular degeneration |
| US8445674B2 (en) * | 2009-10-21 | 2013-05-21 | Hoffmann-La Roche Inc | Heterocyclyl compounds |
| CN102050809B (zh) * | 2009-11-03 | 2014-12-17 | 中国医学科学院药物研究所 | 拮抗cklf1/ccr4相互作用的3-哌嗪基香豆素衍生物 |
| UA109290C2 (uk) | 2010-10-07 | 2015-08-10 | Спільні кристали і солі інгібіторів ccr3 | |
| US10213421B2 (en) | 2012-04-04 | 2019-02-26 | Alkahest, Inc. | Pharmaceutical formulations comprising CCR3 antagonists |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1401549A (en) * | 1972-07-07 | 1975-07-16 | Hisamitsu Pharmaceutical Co | Pyrido-2,3-d-pyrimidine-2,4-1h,3h- diones and methods of preparing them |
| US3922275A (en) * | 1972-11-09 | 1975-11-25 | Hisamitsu Pharmaceutical Co | Pyrido{8 2,3-D{9 {0 pyrimidine-2,4(1H,3H)-diones |
| US4335127A (en) * | 1979-01-08 | 1982-06-15 | Janssen Pharmaceutica, N.V. | Piperidinylalkyl quinazoline compounds, composition and method of use |
| DE3172006D1 (en) * | 1980-05-22 | 1985-10-03 | Masayuki Ishikawa | Novel quinazoline-dione compounds, process for production thereof and pharmaceutical use thereof |
| US4695575A (en) * | 1984-11-13 | 1987-09-22 | Janssen Pharmaceutica, N.V. | 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines |
| US4839374A (en) * | 1984-01-09 | 1989-06-13 | Janssen Pharmaceutica, N.V. | 4-((Bicyclic heterocyclyl)-methyl and -hetero)-piperidines |
| JPH0615529B2 (ja) * | 1985-04-01 | 1994-03-02 | エーザイ株式会社 | 新規ピペリジン誘導体 |
| US5143923B1 (en) * | 1991-04-29 | 1993-11-02 | Hoechst-Roussel Pharmaceuticals Incorporated | Benzoisothiazole-and benzisoxazole-3-carboxamides |
| US6126964A (en) * | 1996-01-04 | 2000-10-03 | Mirus Corporation | Process of making a compound by forming a polymer from a template drug |
| AU3906997A (en) * | 1996-08-01 | 1998-02-25 | Isis Pharmaceuticals, Inc. | Novel heterocycle compositions |
| FR2753970B1 (fr) * | 1996-10-01 | 1998-10-30 | Synthelabo | Derives de n-(benzothiazol-2-yl) piperidine-1-ethanamine, leur preparation et leur application en therapeutique |
| IL125658A0 (en) * | 1997-08-18 | 1999-04-11 | Hoffmann La Roche | Ccr-3 receptor antagonists |
| US6084098A (en) * | 1999-02-26 | 2000-07-04 | Neurogen Corporation | Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands |
| CA2345944A1 (en) * | 1998-09-30 | 2000-04-06 | Neurogen Corporation | 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands |
| US6284759B1 (en) * | 1998-09-30 | 2001-09-04 | Neurogen Corporation | 2-piperazinoalkylaminobenzo-azole derivatives: dopamine receptor subtype specific ligands |
| BR9915403A (pt) * | 1998-11-17 | 2001-08-14 | Hoffmann La Roche | Antagonistas receptores iii de 4-aroil-piperidin-ccr-3 |
| AU1774600A (en) * | 1998-11-20 | 2000-06-13 | F. Hoffmann-La Roche Ag | Piperidine ccr-3 receptor antagonists |
| CA2350903A1 (en) * | 1998-11-20 | 2000-06-02 | F. Hoffmann-La Roche Ag | Pyrrolidine derivatives-ccr-3 receptor antagonists |
| IL144353A0 (en) * | 1999-03-26 | 2002-05-23 | Astrazeneca Ab | Novel compounds |
| WO2000076967A1 (en) * | 1999-06-14 | 2000-12-21 | Neurogen Corporation | Benzylpiperazinyl-indolinylethanones |
| US6476041B1 (en) * | 1999-10-29 | 2002-11-05 | Merck & Co., Inc. | 1,4 substituted piperidinyl NMDA/NR2B antagonists |
| DK1260512T3 (da) * | 2000-02-29 | 2007-11-05 | Mitsubishi Pharma Corp | Hidtil ukendte, cykliske amidderivater |
| AU2001292276A1 (en) * | 2000-09-27 | 2002-04-08 | Toray Industries, Inc. | Nitrogen-containing compounds and ccr3 inhibitors containing the same as the active ingredient |
| CN1239498C (zh) * | 2000-12-19 | 2006-02-01 | 霍夫曼-拉罗奇有限公司 | 作为ccr－3受体拮抗剂的取代的吡咯烷 |
| GB0203299D0 (en) * | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel compounds |
| JPWO2004011430A1 (ja) * | 2002-07-25 | 2005-11-24 | アステラス製薬株式会社 | ナトリウムチャネル阻害剤 |
-
2004
- 2004-10-14 BR BRPI0415767-2A patent/BRPI0415767A/pt not_active Application Discontinuation
- 2004-10-14 MX MXPA06004304A patent/MXPA06004304A/es not_active Application Discontinuation
- 2004-10-14 AU AU2004283842A patent/AU2004283842A1/en not_active Abandoned
- 2004-10-14 RU RU2006117631/04A patent/RU2006117631A/ru not_active Application Discontinuation
- 2004-10-14 CN CNA2004800311310A patent/CN1871222A/zh active Pending
- 2004-10-14 WO PCT/EP2004/011545 patent/WO2005040129A2/en active Application Filing
- 2004-10-14 JP JP2006536005A patent/JP2007509095A/ja active Pending
- 2004-10-14 SG SG200702988-7A patent/SG131946A1/en unknown
- 2004-10-14 KR KR1020067007870A patent/KR20060061393A/ko not_active Application Discontinuation
- 2004-10-14 EP EP04790404A patent/EP1680408A2/en not_active Withdrawn
- 2004-10-14 CA CA002543419A patent/CA2543419A1/en not_active Abandoned
- 2004-10-22 TW TW093132290A patent/TW200522957A/zh unknown
- 2004-10-22 AR ARP040103835A patent/AR046340A1/es unknown
- 2004-10-25 US US10/972,564 patent/US20050090504A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20050090504A1 (en) | 2005-04-28 |
| MXPA06004304A (es) | 2006-06-05 |
| CA2543419A1 (en) | 2005-05-06 |
| EP1680408A2 (en) | 2006-07-19 |
| WO2005040129A3 (en) | 2005-06-23 |
| CN1871222A (zh) | 2006-11-29 |
| TW200522957A (en) | 2005-07-16 |
| JP2007509095A (ja) | 2007-04-12 |
| WO2005040129A2 (en) | 2005-05-06 |
| RU2006117631A (ru) | 2007-12-10 |
| BRPI0415767A (pt) | 2006-12-26 |
| AR046340A1 (es) | 2005-12-07 |
| KR20060061393A (ko) | 2006-06-07 |
| AU2004283842A1 (en) | 2005-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1090922A1 (en) | Cgrp receptor antagonists cgrp | |
| AP1828A (en) | Muscarinic Acetycholine receptor antagonists | |
| IL174538A0 (en) | Thrombin receptor antagonists | |
| TWI346553B (en) | Chemokine receptor antagonists | |
| TWI341198B (en) | Hydroisoindoline tachykinin receptor antagonists | |
| AU2003261392A8 (en) | M3muscarinic acetylcholine receptor antagonists | |
| EP1553075A4 (en) | LPA Receptor Antagonists | |
| IL172822A0 (en) | Muscarnic acetylcholine receptor antagonists | |
| TWI348467B (en) | Nk1 antagonists | |
| EP1814550A4 (en) | ANTAGONISTS OF N-SULFONYLPIPERIDINE CANNABINOID RECEPTOR 1 | |
| IL173512A0 (en) | Cyclopropyl derivatives as nk3 receptor antagonists | |
| IL173746A0 (en) | Modified il-4 mutein receptor antagonists | |
| PL378753A1 (pl) | Antagoniści receptora CCR-3 | |
| PL378023A1 (pl) | Merkaptoimidazole jako związki antagonistyczne receptora CCR2 | |
| EP1631559A4 (en) | IL-8 SB / SB RECEPTOR ANTAGONISTS | |
| IL173337A0 (en) | Receptor | |
| SG131946A1 (en) | Ccr3 receptor antagonists | |
| EP1696949A4 (en) | VEGF Receptor Antagonists | |
| AU2003287219A8 (en) | Il-8 receptor antagonists | |
| ZA200605574B (en) | Hydroisoindoline tachykinin receptor antagonists | |
| EP1636230A4 (en) | ADENOSINE A1 RECEPTOR ANTAGONISTS | |
| GB0302094D0 (en) | EP4 receptor antagonists | |
| GB0215389D0 (en) | Receptor | |
| GB0321998D0 (en) | Receptor | |
| GB0317346D0 (en) | 5-ht2b receptor antagonists |